BMS-191011

N/A

Report date: 2024/12/13 09:26:26
NME

Base Information

Drug NameBMS-191011
Drug Alias NameBMS-191011BMS-189269
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium-activated potassium channel alpha/beta 1 agonists
TargetsCalcium-activated potassium channel alpha/beta 1
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A